Diabetic Nephropathy (Study Outline) 1. Background Definit…
Diabetic Nephropathy (Study Outline) 1. Background Definition: A chronic, progressive kidney disease caused by long-term diabetes mellitus, leading to albuminuria, declining GFR, and eventual CKD/ESRD. Epidemiology: Most common cause of ESRD in the U.S. Occurs in both type 1 and type 2 diabetes. Pathophysiology: Chronic hyperglycemia → nonenzymatic glycosylation → basement membrane thickening + mesangial expansion. Glomerular hyperfiltration early → podocyte loss → sclerosis (Kimmelstiel–Wilson nodules). Progression (typical): Hyperfiltration Microalbuminuria Macroalbuminuria Declining GFR ESRD 2. History Often asymptomatic early. Classic early clue: new or worsening microalbuminuria. Later symptoms relate to CKD: fatigue, edema, nocturia. Longstanding diabetes (poor control, long duration). Coexisting diabetic complications: retinopathy (high-yield), neuropathy. Cardiovascular risk factors: HTN, dyslipidemia, obesity. 3. Exam Findings Blood pressure: usually elevated. Edema: peripheral or periorbital as protein loss increases. Diabetic complications: Retinopathy (high-yield correlation with nephropathy). Peripheral neuropathy. Signs of advanced CKD: pallor (anemia), asterixis, crackles (volume overload). 4. Making the Diagnosis Urine testing: Urine albumin-to-creatinine ratio (ACR): Microalbuminuria = 30–300 mg/day equivalent. Macroalbuminuria >300 mg/day. Persistent albuminuria on ≥2 tests over 3 months. Urinalysis: Proteinuria; may progress to nephrotic-range. No hematuria typically (unless another renal disease). Renal function: Gradual decline in GFR; increasing BUN/Cr. Serology: usually normal (normal complements, no immune markers). Imaging: renal ultrasound normal or enlarged early; may be small later. Renal biopsy: Not routinely required unless atypical. Would show Kimmelstiel–Wilson nodules (nodular glomerulosclerosis). Gold Standard: Persistent albuminuria + diabetic history + absence of alternative cause, confirmed clinically. 5. Management (Exam Concepts) Glycemic control: Tight glucose management slows progression (exam concept; no regimen details). BP management: RAAS modulation principles reduce intraglomerular pressure and proteinuria (high-yield). Proteinuria reduction: Central to slowing disease progression. Lifestyle concepts: Sodium restriction for edema/BP; weight management. CKD complication monitoring: Hyperkalemia, acidosis, anemia, bone-mineral disease, hyperphosphatemia. Avoid nephrotoxins and adjust doses of renally cleared medications. Cardiovascular risk reduction: Diabetes + nephropathy markedly increases CV mortality. Dialysis indications: AEIOU concept if ESRD develops. Referral: albuminuria progression, rapid GFR decline, uncertainty in diagnosis, or need for renal replacement planning. QUESTION A 62-year-old woman with a 20-year history of poorly controlled type 2 diabetes presents for routine follow-up. She reports increased lower extremity swelling and fatigue. Vitals reveal a blood pressure of 152/92 mmHg. Fundoscopic exam shows background diabetic retinopathy. Physical exam reveals bilateral pitting edema to the mid-shin. Laboratory findings include: Serum creatinine: 1.8 mg/dL (baseline 1.0 mg/dL one year ago) Urine albumin-to-creatinine ratio: 820 mg/g Serum potassium: 4.9 mEq/L Hemoglobin A1c: 9.1% ANA, C3/C4: normal Which of the following is the most appropriate next step in management to slow the progression of her renal disease? A) Begin sodium bicarbonate therapyB) Initiate an ACE inhibitorC) Schedule a renal biopsyD) Start high-dose corticosteroids